Results 31 to 40 of about 97,920 (228)

A multicenter prospective study of 515 febrile neutropenia episodes in Argentina during a 5-year period.

PLoS ONE, 2019
For better management of patients with febrile neutropenia, our study investigated the epidemiologic, microbiologic, and clinical characteristics of adult inpatients with febrile neutropenia and their mortality-associated factors. To this end, we carried
Roberto L Parodi, Mariana Lagrutta, Mauro Tortolo, Estefanía Navall, María S Rodríguez, Gervasio F Sasia, Lucas F De Candia, Matias A Gruvman, Oscar Bottasso, Alcides A Greca   +9 more
doaj   +1 more source

Efficacy and Safety of Filgrastim and Its Biosimilars to Prevent Febrile Neutropenia in Cancer Patients: A Prospective Study and Meta-Analysis

Biology, 2021
Background: The aim of this review and meta-analysis was to identify, assess, meta-analyze and summarize the comparative effectiveness and safety of filgrastim in head-to-head trials with placebo/no treatment, pegfilgrastim (and biosimilar filgrastim to ...
Shruti Rastogi, Vivekananda Kalaiselvan, Sher Ali, Ajaz Ahmad, Sameer Ahmad Guru, Maryam Sarwat   +5 more
doaj   +1 more source

Effect of Designing Nursing Protocol regarding Chemotherapy Induced Febrile Neutropenia: Nurses performance and Patients’ related Outcome [PDF]

Tanta Scientific Nursing Journal
Background: Febrile neutropenia  is serious complication of many chemotherapy regimen, the   Oncology nurses serve as key frontline providers in the execution of clinical protocols designed for febrile neutropenia care.
Amany Abdallah, Seham Abd El-Hay, Shimaa Farghaly, Alyaa Mohammed Elseadi   +3 more
doaj   +1 more source

Risk Adapted Management of Febrile Neutrepenia and Early Cessation of Empirical Antibiotherapy in Hematopoietic Stem Cell Transplantation Setting

Balkan Medical Journal, 2017
Background: Haematopoietic stem cell transplantation is a curative treatment option for many haematological disorders. Infection following haematopoietic stem cell transplantation is one of the major causes of mortality.
Ali Hakan Kaya, Emre Tekgündüz, Fazilet Duygu, Dicle Koca, Filiz Bekdemir, Hikmetullah Batgi, Bahar Ulu Uncu, Tuğçe Nur Yiğenoğlu, Mehmet Sinan Dal, Merih Çakar Kızıl, Fevzi Altuntaş   +10 more
doaj   +1 more source

Open-labeled, multicenter phase II study of prophylactic administration of pegylated granulocyte colony-stimulating factor in relapsed or refractory multiple myeloma who received pomalidomide-based regimens (KMM170)

Frontiers in Oncology, 2023
IntroductionPegylated granulocyte colony-stimulating factor (G-CSF) has been widely used for preventing febrile neutropenia in various types of cancer treatment. In the present study, we prospectively evaluated the safety and efficacy of pegfilgrastim as
Ga-Young Song, Je-Jung Lee, Joon Ho Moon, Dajung Kim, Min Kyoung Kim, Hyo Jung Kim, Yeung-Chul Mun, Won-Sik Lee, Young Rok Do, Jae Hoon Lee, Sung-Hoon Jung, Jin Seok Kim   +11 more
doaj   +1 more source

Febrile neutropenia events between decitabine monotherapy vs decitabine combination.

, 2022
Febrile neutropenia events between decitabine monotherapy vs decitabine combination.
Romina Brignardello-Petersen (814592), Pinkal Desai (10499402), Luis Enrique Colunga-Lozano (12035353), Arnav Agarwal (649596), Mikkael A. Sekeres (9122702), Gordon H. Guyatt (9501499), Fernando Kenji Nampo (6646001), Mark Litzow (12035356)   +7 more
core   +1 more source

Antimicrobial de-escalation in patients with high-risk febrile neutropenia: Attitudes and practices of adult hospital care providers

Antimicrobial Stewardship & Healthcare Epidemiology, 2021
In a survey of adult hospital providers regarding antibiotic use in the treatment of febrile neutropenia, clinical fellows, and pharmacists showed higher comfort levels with early antimicrobial de-escalation compared to hematology-oncology and transplant
Chelsea A. Gorsline, Milner B. Staub, George E. Nelson, Whitney J. Nesbitt, Bhagirathbhai R. Dholaria, Gowri Satyanarayana   +5 more
doaj   +1 more source

Febrile neutropenia in chemotherapy treated small-cell lung cancer patients

Radiology and Oncology, 2015
Background. Chemotherapy with platinum agent and etoposide for small-cell lung cancer (SCLC) is supposed to be associated with intermediate risk (10-20%) of febrile neutropenia.
Kukec Renata Rezonja, Grabnar Iztok, Vovk Tomaz, Mrhar Ales, Kovac Viljem, Cufer Tanja   +5 more
doaj   +1 more source

Risk factors for the onset of febrile neutropenia.

, 2022
Risk factors for the onset of febrile neutropenia.
Hiroyuki Kubo (2694157), Yukiko Hamasaki Kubo (12256737), Osamu Imataki (188246), Makiko Uemura (3619295)   +3 more
core   +1 more source

Level of Knowledge and Incidence of Emergency Oncology: Febrile Neutropenia in Hematologic Cancer Patients Post Chemotherapy: A Descriptive Study

Masker Medika
Introduction: Febrile neutropenia is a life-threatening condition that is the most common oncological emergency, especially in cases of hematological cancer. Knowledge related to this condition can accelerate treatment and reduce mortality. The danger of
Agus Suryaman
doaj   +1 more source